T2 Biosystems Inc Buchwert je Aktie
Was ist das Buchwert je Aktie von T2 Biosystems Inc?
Buchwert je Aktie von T2 Biosystems Inc ist -6.20
Was ist die Definition von Buchwert je Aktie?
Der Buchwert pro Aktie ist das Vermögen eines Unternehmens abzüglich der Verbindlichkeiten geteilt durch die Anzahl der ausstehenden Aktien.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Buchwert je Aktie von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu T2 Biosystems Inc
Was macht T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Unternehmen mit buchwert je aktie ähnlich T2 Biosystems Inc
- Novavax hat Buchwert je Aktie von -6.51
- American Airlines Inc hat Buchwert je Aktie von -6.46
- Vector Ltd hat Buchwert je Aktie von -6.37
- Dine Brands Global Inc hat Buchwert je Aktie von -6.36
- Mettler-Toledo International hat Buchwert je Aktie von -6.33
- Harte Hanks hat Buchwert je Aktie von -6.26
- T2 Biosystems Inc hat Buchwert je Aktie von -6.20
- i-nexus Global plc hat Buchwert je Aktie von -6.20
- Lowe's Companies hat Buchwert je Aktie von -6.17
- Wyndham Destinations Inc hat Buchwert je Aktie von -6.17
- Quantum Corp hat Buchwert je Aktie von -6.15
- Simbhaoli Sugars hat Buchwert je Aktie von -6.12
- Bridgemarq Real Estate Services hat Buchwert je Aktie von -6.08